Scientific Publications

Long-residence-time nano-scale liposomal iohexol for X-ray-based blood pool imaging.
Kao CY, Hoffman EA, Beck KC, Bellamkonda RV, Annapragada AV.
Acad Radiol. 2003 May;10(5):475-83.

A liposomal nanoscale contrast agent for preclinical CT in mice.
Mukundan S Jr, Ghaghada KB, Badea CT, Kao CY, Hedlund LW, Provenzale JM, Johnson GA, Chen E, Bellamkonda RV, Annapragada A.
AJR Am J Roentgenol. 2006 Feb;186(2):300-7.

Imaging of pulmonary embolism and t-PA therapy effects using MDCT and liposomal iohexol blood pool agent: preliminary results in a rabbit model.
Burke SJ, Annapragada A, Hoffman EA, Chen E, Ghaghada KB, Sieren J, van Beek EJ.
Acad Radiol. 2007 Mar;14(3):355-62.

Multifunctional nanocarriers for mammographic quantification of tumor dosing and prognosis of breast cancer therapy.
Karathanasis E, Chan L, Balusu SR, D'Orsi CJ, Annapragada AV, Sechopoulos I, Bellamkonda RV.
Biomaterials. 2008 Dec;29(36):4815-22.

Imaging nanoprobe for prediction of outcome of nanoparticle chemotherapy by using mammography.
Karathanasis E, Suryanarayanan S, Balusu SR, McNeeley K, Sechopoulos I, Karellas A, Annapragada AV, Bellamkonda RV.
Radiology. 2009 Feb;250(2):398-406.

Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers.
Karathanasis E, Chan L, Karumbaiah L, McNeeley K, D'Orsi CJ, Annapragada AV, Sechopoulos I, Bellamkonda RV.
PLoS One. 2009 Jun 9;4(6):e5843.

Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent.
Samei E, Saunders RS, Badea CT, Ghaghada KB, Hedlund LW, Qi Y, Yuan H, Bentley RC, Mukundan S Jr.
Int J Nanomedicine. 2009;4:277-82.